 |
|
Long-term Efficacy of Intranasal Mupirocin OintmentA Prospective Cohort Study of Staphylococcus aureus Carriage
Bradley N. Doebbeling, MD, MS;
David R. Reagan, MD, PhD;
Michael A. Pfaller, MD;
Alison K. Houston;
Richard J. Hollis, MA;
Richard P. Wenzel, MD, MSc
Arch Intern Med. 1994;154(13):1505-1508.
Abstract
Background
We investigated the long-term effect of a single 5-day application of intranasal mupirocin calcium ointment on Staphylococcus aureus nasal and hand colonization. The subjects were 68 healthy volunteers who were health care workers with stable S aureus nasal carriage and who had participated in a randomized, double-blind, placebo-controlled clinical trial of intranasal mupirocin ointment.
Methods
A 1-year prospective cohort study of S aureus nasal carriers after treatment with active drug or placebo was performed. Cultures were obtained from all subjects 6 and 12 months after therapy. All subjects returned for the 6-month visit; 63 (93%) were examined at 1 year. The major outcome measure was the relative proportion of any S aureus cultured at either site at 6 and 12 months. The S aureus isolates were typed by restriction endonuclease analysis of plasmid DNA and by antibiotic susceptibility tests; the similarity of nasal and hand isolate "fingerprints" was compared.
Results
At 6 months, nasal carriage was 48% in the treatment group vs 72% in controls (relative risk, 0.68; 95% confidence interval, 0.45 to 1.02; P=.054); at 1 year, nasal carriage was 53% vs 76%, respectively (relative risk, 0.70; 95% confidence interval, 0.48 to 1.02; P=.056). Hand carriage at 6 months was significantly reduced among mupirocin recipients relative to controls (15% and 48%; P=.04, adjusted for the baseline rate of hand carriage). Thirty-six percent of treated subjects were recolonized in the nares with a new strain at 1 year, whereas 34% had reisolation of the original strain after initially negative posttherapy cultures. During the year of follow-up, hand carriage was observed at least once in two thirds of the subjects. Nearly all of the hand isolates (87%) exactly matched the subjects' coincident nasal plasmid fingerprint and antibiogram type.
Conclusions
A single brief treatment course of intranasal mupirocin was effective in reducing nasal S aureus carriage for up to 1 year. When S aureus was recovered after nasal decolonization, the new isolate was as likely to represent colonization with a new strain as reisolation of the original strain. Staphylococcus aureus hand carriage was significantly decreased 6 months after therapy, further implicating the nares as the primary reservoir site for hand carriage.
(Arch Intern Med. 1994;154:1505-1508)
Author Affiliations
From the University of Iowa College of Medicine (Drs Doebbeling, Reagan, Pfaller, and Wenzel, Ms Houston, and Mr Hollis); Department of Veterans Affairs Medical Center (Dr Doebbeling); and University of Iowa Hospitals and Clinics, Iowa City (Drs Pfaller and Wenzel). Dr Reagan is now with James H. Quillen College of Medicine, East Tennessee State University, Johnson City.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus
Boucher et al.
Clinical Infectious Diseases 2010;51:S183-S197.
ABSTRACT
| FULL TEXT
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
Coates et al.
J Antimicrob Chemother 2009;64:9-15.
ABSTRACT
| FULL TEXT
Eradication of Methicillin-Resistant Staphylococcus aureus Carriage: A Systematic Review
Ammerlaan et al.
Clinical Infectious Diseases 2009;48:922-930.
ABSTRACT
| FULL TEXT
Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
Miller and Diep
Clinical Infectious Diseases 2008;46:752-760.
ABSTRACT
| FULL TEXT
Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals
Simor et al.
Antimicrob. Agents Chemother. 2007;51:3880-3886.
ABSTRACT
| FULL TEXT
Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial
Ellis et al.
Antimicrob. Agents Chemother. 2007;51:3591-3598.
ABSTRACT
| FULL TEXT
Mupirocin-Based Decolonization of Staphylococcus aureus Carriers in Residents of 2 Long-Term Care Facilities: A Randomized, Double-Blind, Placebo-Controlled Trial
Mody et al.
Clinical Infectious Diseases 2003;37:1467-1474.
ABSTRACT
| FULL TEXT
Treatment of Staphylococcus aureus Colonization and Prophylaxis for Infection with Topical Intranasal Mupirocin: An Evidence-Based Review
Laupland and Conly
Clinical Infectious Diseases 2003;37:933-938.
ABSTRACT
| FULL TEXT
Development and Characterization of a Staphylococcus aureus Nasal Colonization Model in Mice
Kiser et al.
Infect. Immun. 1999;67:5001-5006.
ABSTRACT
| FULL TEXT
Risk Factors for Hospital-Acquired Staphylococcus aureus Bacteremia
Jensen et al.
Arch Intern Med 1999;159:1437-1444.
ABSTRACT
| FULL TEXT
A 1-Year Trial of Nasal Mupirocin in the Prevention of Recurrent Staphylococcal Nasal Colonization and Skin Infection
Raz et al.
Arch Intern Med 1996;156:1109-1112.
ABSTRACT
Mupirocin Calcium Ointment for Long-term Eradication of S. aureus Nasal Carriage
Journal Watch Dermatology 1994;1994:1-1.
FULL TEXT
NASAL MUPIROCIN OINTMENT FOR S. AUREUS CARRIAGE
JWatch General 1994;1994:5-5.
FULL TEXT
|
